Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial (Q34906164)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial |
scientific article |
Statements
1 reference
Imatinib mesylate (Gleevec) in the treatment of diffuse cutaneous systemic sclerosis: results of a 1-year, phase IIa, single-arm, open-label clinical trial (English)
1 reference
Robert F Spiera
1 reference
Jessica K Gordon
1 reference
Jamie N Mersten
1 reference
Cynthia M Magro
1 reference
Mansi Mehta
1 reference
Horatio F Wildman
1 reference
Stacey Kloiber
1 reference
Kyriakos A Kirou
1 reference
Stephen Lyman
1 reference
Mary K Crow
1 reference
11 March 2011
1 reference
1 reference
70
1 reference
6
1 reference
1003-1009
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference